At SKIM we have learned from studies over the past few years, that not only lower costs but also many complex factors need to be considered in order to determine future impact of biosimilars. Understanding how these factors will influence uptake and how this may evolve over time will be essential for originator companies to build effective strategies across therapy areas, settings, and countries.
In this webinar you will learn about:
©2024 SKIM